Covered recipient · General Payments record

AJAI CHARI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI: 1376560136
CMS profile: 334925
Location: NEW YORK, NY

General Payments · PY2018–2024

$432,537.55

Reported across 404 records
CMS publication 2026-01-23

Latest program year · PY2024

$93,611.35

74 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Consulting Fee	$70,119.06	16
Travel and Lodging	$16,815.65	28
Honoraria	$5,000.00	2
Food and Beverage	$1,426.64	27
Gift	$250.00	1

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Takeda Pharmaceuticals U.S.A., Inc.	$33,544.30	6
Octapharma USA, Inc.	$13,231.29	18
GENZYME CORPORATION	$10,890.88	6
E.R. Squibb & Sons, L.L.C.	$7,391.86	4
GlaxoSmithKline, LLC.	$7,315.31	7
F. Hoffmann-La Roche AG	$6,080.00	2
Kite Pharma, Inc.	$4,120.00	3
Acerta Pharma LLC	$3,767.50	1
Legend Biotech USA Inc.	$2,573.13	5
Karyopharm Therapeutics Inc.	$2,296.16	3
Janssen Global Services, LLC	$724.04	3
Janssen Research & Development, LLC	$703.10	6
ABBVIE INC.	$337.50	1
Sekisui Diagnostics LLC	$250.00	1
Celgene Corporation	$191.72	5
Janssen Biotech, Inc.	$134.56	2
AstraZeneca UK Limited	$60.00	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$68,921.92	111
PY2019	$86,988.45	90
PY2020	$64,231.69	37
PY2021	$30,261.06	20
PY2022	$37,247.32	28
PY2023	$51,275.76	44
PY2024	$93,611.35	74

Payment records · PY2024 (74)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$337.50	03/22/2024	Consulting Fee	Undisputed	01/23/2026	1103132757	CMS
AstraZeneca Pharmaceuticals LP	$3,767.50	01/25/2024	Consulting Fee	Undisputed	01/23/2026	1104731257	CMS
AstraZeneca UK Limited	$60.00	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1094025598	CMS
Celgene Corporation	$49.35	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1101173498	CMS
Celgene Corporation	$29.23	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1101173504	CMS
Celgene Corporation	$26.94	12/10/2024	Food and Beverage	Undisputed	01/23/2026	1101173528	CMS
Celgene Corporation	$26.94	12/10/2024	Food and Beverage	Undisputed	01/23/2026	1101173530	CMS
Celgene Corporation	$59.26	12/10/2024	Food and Beverage	Undisputed	01/23/2026	1101173532	CMS
E.R. Squibb & Sons, L.L.C.	$2,422.00	04/04/2024	Consulting Fee	Undisputed	01/23/2026	1101691159	CMS
E.R. Squibb & Sons, L.L.C.	$1,612.36	05/01/2024	Consulting Fee	Undisputed	01/23/2026	1101691162	CMS
E.R. Squibb & Sons, L.L.C.	$15.00	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1101691224	CMS
E.R. Squibb & Sons, L.L.C.	$3,342.50	12/23/2024	Consulting Fee	Undisputed	01/23/2026	1101691221	CMS
F. Hoffmann-La Roche AG	$4,560.00	01/29/2024	Consulting Fee	Undisputed	01/23/2026	1132972999	CMS
F. Hoffmann-La Roche AG	$1,520.00	04/01/2024	Consulting Fee	Undisputed	01/23/2026	1132973001	CMS
GENZYME CORPORATION	$167.17	07/11/2024	Food and Beverage	Undisputed	01/23/2026	1139694626	CMS
GENZYME CORPORATION	$270.07	07/11/2024	Travel and Lodging	Undisputed	01/23/2026	1139694630	CMS
GENZYME CORPORATION	$312.46	07/11/2024	Travel and Lodging	Undisputed	01/23/2026	1139694632	CMS
GENZYME CORPORATION	$9,972.00	07/11/2024	Consulting Fee	Undisputed	01/23/2026	1139694636	CMS
GENZYME CORPORATION	$20.83	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1139694628	CMS
GENZYME CORPORATION	$148.35	09/13/2024	Travel and Lodging	Undisputed	01/23/2026	1139694634	CMS
GlaxoSmithKline, LLC.	$72.25	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1115936645	CMS
GlaxoSmithKline, LLC.	$25.88	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1116348286	CMS
GlaxoSmithKline, LLC.	$2,275.00	07/15/2024	Consulting Fee	Undisputed	01/23/2026	1116679015	CMS
GlaxoSmithKline, LLC.	$4,800.00	10/08/2024	Consulting Fee	Undisputed	01/23/2026	1116584405	CMS
GlaxoSmithKline, LLC.	$38.18	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1116255435	CMS
GlaxoSmithKline, LLC.	$48.00	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1116654959	CMS
GlaxoSmithKline, LLC.	$56.00	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1116658459	CMS
Janssen Biotech, Inc.	$67.29	12/07/2024	Food and Beverage	Undisputed	01/23/2026	1078456178	CMS
Janssen Biotech, Inc.	$67.27	12/07/2024	Food and Beverage	Undisputed	01/23/2026	1078457062	CMS
Janssen Global Services, LLC	$675.00	06/14/2024	Consulting Fee	Undisputed	01/23/2026	1077592053	CMS
Janssen Global Services, LLC	$39.40	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1077592009	CMS
Janssen Global Services, LLC	$9.64	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1077592017	CMS
Janssen Research & Development, LLC	$68.32	11/21/2024	Travel and Lodging	Undisputed	01/23/2026	1077588595	CMS
Janssen Research & Development, LLC	$516.90	11/21/2024	Travel and Lodging	Undisputed	01/23/2026	1077588597	CMS
Janssen Research & Development, LLC	$18.27	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1077588609	CMS
Janssen Research & Development, LLC	$13.69	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1077588629	CMS
Janssen Research & Development, LLC	$40.92	11/21/2024	Travel and Lodging	Undisputed	01/23/2026	1077588663	CMS
Janssen Research & Development, LLC	$45.00	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1077588725	CMS
Karyopharm Therapeutics Inc.	$15.50	09/25/2024	Travel and Lodging	Undisputed	01/23/2026	1145527585	CMS
Karyopharm Therapeutics Inc.	$243.16	09/25/2024	Food and Beverage	Undisputed	01/23/2026	1145527587	CMS
Karyopharm Therapeutics Inc.	$2,037.50	09/25/2024	Consulting Fee	Undisputed	01/23/2026	1145527589	CMS
Kite Pharma, Inc.	$50.00	03/22/2024	Food and Beverage	Undisputed	01/23/2026	1128609657	CMS
Kite Pharma, Inc.	$50.00	03/22/2024	Food and Beverage	Undisputed	01/23/2026	1128609659	CMS
Kite Pharma, Inc.	$4,020.00	04/12/2024	Consulting Fee	Undisputed	01/23/2026	1128609655	CMS
Legend Biotech USA Inc.	$4.65	06/10/2024	Travel and Lodging	Undisputed	01/23/2026	1131689845	CMS
Legend Biotech USA Inc.	$25.50	06/10/2024	Travel and Lodging	Undisputed	01/23/2026	1131690078	CMS
Legend Biotech USA Inc.	$6.75	06/10/2024	Food and Beverage	Undisputed	01/23/2026	1131691174	CMS
Legend Biotech USA Inc.	$2,462.50	07/03/2024	Consulting Fee	Undisputed	01/23/2026	1131692067	CMS
Legend Biotech USA Inc.	$73.73	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1131694481	CMS
Octapharma USA, Inc.	$2,500.00	06/13/2024	Honoraria	Undisputed	01/23/2026	1142313188	CMS
Octapharma USA, Inc.	$59.85	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313190	CMS
Octapharma USA, Inc.	$14.97	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313192	CMS
Octapharma USA, Inc.	$17.11	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313194	CMS
Octapharma USA, Inc.	$8.55	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313196	CMS
Octapharma USA, Inc.	$10.76	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313198	CMS
Octapharma USA, Inc.	$16.10	06/13/2024	Travel and Lodging	Undisputed	01/23/2026	1142313200	CMS
Octapharma USA, Inc.	$2,500.00	06/14/2024	Honoraria	Undisputed	01/23/2026	1142313202	CMS
Octapharma USA, Inc.	$7,000.00	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313204	CMS
Octapharma USA, Inc.	$240.71	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313206	CMS
Octapharma USA, Inc.	$240.71	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313208	CMS
Octapharma USA, Inc.	$240.71	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313210	CMS
Octapharma USA, Inc.	$240.71	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313212	CMS
Octapharma USA, Inc.	$29.38	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313214	CMS
Octapharma USA, Inc.	$23.67	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313216	CMS
Octapharma USA, Inc.	$12.90	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313218	CMS
Octapharma USA, Inc.	$16.00	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313220	CMS
Octapharma USA, Inc.	$59.16	06/14/2024	Travel and Lodging	Undisputed	01/23/2026	1142313222	CMS
Sekisui Diagnostics, LLC	$250.00	02/22/2024	Gift	Undisputed	01/23/2026	1127502573	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$5,864.00	05/07/2024	Consulting Fee	Undisputed	01/23/2026	1137507979	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$7,023.23	07/18/2024	Travel and Lodging	Undisputed	01/23/2026	1144955125	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$47.41	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1144955127	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$123.47	11/12/2024	Travel and Lodging	Undisputed	01/23/2026	1144955129	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$34.99	11/12/2024	Travel and Lodging	Undisputed	01/23/2026	1144955131	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$20,451.20	11/12/2024	Consulting Fee	Undisputed	01/23/2026	1144955133	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.